Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists
Search results for: methotrexate
Giant Cell Arteritis Challenging to Diagnose, Manage
Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets
2014 ACR/ARHP Annual Meeting: Fibrotic Complications of Scleroderma
Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment
2014 ACR/ARHP Annual Meeting: Psoriatic Arthritis
Clinical manifestations, approaches to diagnosis, treatment
Metabolic Biosensor Implicated in Gout
AMP-activated protein kinase may be link between nutritional excess, inflammation that leads to gout
Biomarkers in Rheumatoid Arthritis Remain Elusive
Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient
2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News
Plus, hydrocodone combination products and brodalumab
The ACR/ARHP Member News
Awards, appointments and announcements in the world of rheumatology
The ACR/ARHP Annual Meeting: Rheumatoid Arthritis Raises Mortality Risk in Women
Data from Nurses’ Health Study, other clinical trials point to higher risk of respiratory, cardiovascular disease death in women with RA
Coding Corner Questions: January
Coding cases of drug-induced gout, systemic lupus erythematosus with lung involvement, inflammatory rheumatoid arthritis, osteoporosis
- « Previous Page
- 1
- …
- 73
- 74
- 75
- 76
- 77
- …
- 101
- Next Page »